| Veröffentlichte Version Download ( PDF | 2MB) | Lizenz: Creative Commons Namensnennung 4.0 International |
NanoBRET binding assay for histamine H2 receptor ligands using live recombinant HEK293T cells
Grätz, Lukas, Tropmann, Katharina, Bresinsky, Merlin, Müller, Christoph, Bernhardt, Günther
und Pockes, Steffen
(2020)
NanoBRET binding assay for histamine H2 receptor ligands using live recombinant HEK293T cells.
Scientific Reports 10, S. 13288.
Veröffentlichungsdatum dieses Volltextes: 19 Feb 2021 13:06
Artikel
DOI zum Zitieren dieses Dokuments: 10.5283/epub.44991
Zusammenfassung
Fluorescence/luminescence-based techniques play an increasingly important role in the development of test systems for the characterization of future drug candidates, especially in terms of receptor binding in the field of G protein-coupled receptors (GPCRs). In this article, we present the establishment of a homogeneous live cell-based BRET binding assay for the histamine H-2 receptor with ...
Fluorescence/luminescence-based techniques play an increasingly important role in the development of test systems for the characterization of future drug candidates, especially in terms of receptor binding in the field of G protein-coupled receptors (GPCRs). In this article, we present the establishment of a homogeneous live cell-based BRET binding assay for the histamine H-2 receptor with different fluorescently labeled squaramide-type compounds synthesized in the course of this study. Py-1-labeled ligand 8 (UR-KAT478) was found to be most suitable in BRET saturation binding experiments with respect to receptor affinity (pK(d) = 7.35) and signal intensity. Real-time kinetic experiments showed a full association of 8 within approximately 30 min and a slow dissociation of the ligand from the receptor. Investigation of reference compounds in BRET-based competition binding with 8 yielded pK(i) values in agreement with radioligand binding data. This study shows that the BRET binding assay is a versatile test system for the characterization of putative new ligands at the histamine H-2 receptor and represents a valuable fluorescence-based alternative to canonical binding assays.
Alternative Links zum Volltext
Beteiligte Einrichtungen
Details
| Dokumentenart | Artikel | ||||
| Titel eines Journals oder einer Zeitschrift | Scientific Reports | ||||
| Verlag: | Nature | ||||
|---|---|---|---|---|---|
| Ort der Veröffentlichung: | BERLIN | ||||
| Band: | 10 | ||||
| Seitenbereich: | S. 13288 | ||||
| Datum | 6 August 2020 | ||||
| Institutionen | Chemie und Pharmazie > Institut für Pharmazie Chemie und Pharmazie > Institut für Pharmazie > Lehrstuhl Pharmazeutische / Medizinische Chemie I (Prof. Elz) | ||||
| Identifikationsnummer |
| ||||
| Stichwörter / Keywords | CONSTITUTIVE ACTIVITY; RECEPTOR ANTAGONIST; ACHE INHIBITOR; POTENT; DIZOCILPINE; SELECTIVITY; BRET; | ||||
| Dewey-Dezimal-Klassifikation | 600 Technik, Medizin, angewandte Wissenschaften > 615 Pharmazie | ||||
| Status | Veröffentlicht | ||||
| Begutachtet | Ja, diese Version wurde begutachtet | ||||
| An der Universität Regensburg entstanden | Ja | ||||
| URN der UB Regensburg | urn:nbn:de:bvb:355-epub-449913 | ||||
| Dokumenten-ID | 44991 |
Downloadstatistik
Downloadstatistik